For decades, the accepted explanation for the origins of the Japanese people was relatively straightforward. Modern Japanese ...

Micron Biomedical, a clinical-stage biotechnology company advancing needle-free vaccines and therapeutics, today announced ...

The Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific is designed for fast, scalable sample analysis. Paired with the Applied Biosystems Axiom™ PharmacoPro™ Array ...

Micron Biomedical today announced the grand opening of its world-class manufacturing facility spanning more than 26,000 ...

According to Verified Market Research®, the Global Luminex Multiplex Assays Market was valued at USD 1.82 Billion in 2025 and ...

Veradermics develops novel dermatology treatments, targeting both adult and pediatric markets with a research-driven approach ...

The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...

The Genomics Core offers a variety of microarray analysis options for DNA and epigenetic studies. The Illumina BeadArray technology combined with the Illumina iScan Array Scanner allows for analysis ...

The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a potential ...